Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Homeostasis Model Assessment for Insulin Resistance Mediates the Positive Association of Triglycerides with DiabetesDiagnostics (Basel), 2024-04, Vol.14 (7), p.733 [Peer Reviewed Journal]COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2075-4418 ;EISSN: 2075-4418 ;DOI: 10.3390/diagnostics14070733 ;PMID: 38611646Full text available |
|
2 |
Material Type: Article
|
Genetic risk score in patients with the APOE2/E2 genotype as a predictor of familial dysbetalipoproteinemiaJournal of clinical lipidology, 2024-03, Vol.18 (2), p.e230 [Peer Reviewed Journal]Copyright © 2023. Published by Elsevier Inc. ;ISSN: 1933-2874 ;EISSN: 1876-4789 ;DOI: 10.1016/j.jacl.2023.11.010 ;PMID: 38044203Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCICardiovascular drugs and therapy, 2023-10, Vol.37 (5), p.941-953 [Peer Reviewed Journal]The Author(s) 2022 ;2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-022-07343-x ;PMID: 35567726Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)Progress in cardiovascular diseases, 2023-07, Vol.79, p.2-11 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0033-0620 ;ISSN: 1873-1740 ;EISSN: 1532-8643 ;DOI: 10.1016/j.pcad.2023.03.001Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) http://creativecommons.org/licenses/by-nc-nd/4.0 ;ISSN: 0033-0620 ;EISSN: 1532-8643 ;DOI: 10.1016/j.pcad.2023.03.001 ;DOI: 10.5167/uzh-257579Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Regional differences in physicians' behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE studyFrontiers in cardiovascular medicine, 2023-06, Vol.10, p.1206551-1206551 [Peer Reviewed Journal]2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella. ;2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella. 2023 Banach, Lewek, Pol, Rabczenko, Balanescu, Blaha, Ceska, Jankowski, Surma, Kolovou, Liberopoulos, Mitu, Mitu, Naji, Paragh, Popławska, Vrablik and Pella ;ISSN: 2297-055X ;EISSN: 2297-055X ;DOI: 10.3389/fcvm.2023.1206551 ;PMID: 37404744Full text available |
|
7 |
Material Type: Article
|
Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemiasPloS one, 2023-05, Vol.18 (5), p.e0272883-e0272883 [Peer Reviewed Journal]Copyright: © 2023 Vrablík et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;2023 Vrablík et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Vrablík et al 2023 Vrablík et al ;2023 Vrablík et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0272883 ;PMID: 37216363Full text available |
|
8 |
Material Type: Article
|
Oral anticoagulant treatment in rheumatoid arthritis patients with atrial fibrillation results of an international auditInternational journal of cardiology. Heart & vasculature, 2022-10, Vol.42, p.101117-101117, Article 101117 [Peer Reviewed Journal]2022 The Authors ;2022 The Authors. ;2022 The Authors. Published by Elsevier B.V. 2022 ;ISSN: 2352-9067 ;EISSN: 2352-9067 ;DOI: 10.1016/j.ijcha.2022.101117 ;PMID: 36118256Full text available |
|
9 |
Material Type: Article
|
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countriesEuropean heart journal. Cardiovascular pharmacotherapy, 2022-09, Vol.8 (6), p.539-548 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;COPYRIGHT 2022 Oxford University Press ;ISSN: 2055-6837 ;EISSN: 2055-6845 ;DOI: 10.1093/ehjcvp/pvab052 ;PMID: 34232315Full text available |
|
10 |
Material Type: Article
|
Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional StudyFrontiers in medicine, 2022-05, Vol.9, p.861419-861419 [Peer Reviewed Journal]Copyright © 2022 Oreska, Storkanova, Kudlicka, Tuka, Mikes, Krupickova, Satny, Chytilova, Kvasnicka, Spiritovic, Hermankova, Cesak, Rybar, Pavelka, Senolt, Mann, Vencovsky, Vrablik and Tomcik. ;Copyright © 2022 Oreska, Storkanova, Kudlicka, Tuka, Mikes, Krupickova, Satny, Chytilova, Kvasnicka, Spiritovic, Hermankova, Cesak, Rybar, Pavelka, Senolt, Mann, Vencovsky, Vrablik and Tomcik. 2022 Oreska, Storkanova, Kudlicka, Tuka, Mikes, Krupickova, Satny, Chytilova, Kvasnicka, Spiritovic, Hermankova, Cesak, Rybar, Pavelka, Senolt, Mann, Vencovsky, Vrablik and Tomcik ;ISSN: 2296-858X ;EISSN: 2296-858X ;DOI: 10.3389/fmed.2022.861419 ;PMID: 35602501Full text available |
|
11 |
Material Type: Article
|
Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical CharacteristicsFrontiers in genetics, 2022-03, Vol.13, p.849267-849267 [Peer Reviewed Journal]Copyright © 2022 Altschmiedova, Todorovova, Vrablik, and Ceska. ;Copyright © 2022 Altschmiedova, Todorovova, Vrablik, and Ceska. 2022 Altschmiedova, Todorovova, Vrablik, and Ceska ;ISSN: 1664-8021 ;EISSN: 1664-8021 ;DOI: 10.3389/fgene.2022.849267 ;PMID: 35368707Full text available |
|
12 |
Material Type: Article
|
Safety and benefit of incretin-based therapies in patients with type 2 diabetes: learnings and reflectionsExpert opinion on drug safety, 2022-03, Vol.21 (3), p.291 [Peer Reviewed Journal]EISSN: 1744-764X ;DOI: 10.1080/14740338.2022.2043848 ;PMID: 35188012Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Beta-blockers for Atherosclerosis Prevention: a Missed Opportunity?Current atherosclerosis reports, 2022-03, Vol.24 (3), p.161 [Peer Reviewed Journal]2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;EISSN: 1534-6242 ;DOI: 10.1007/s11883-022-00983-2 ;PMID: 35174437Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort studyThe Lancet (British edition), 2022-02, Vol.399 (10326), p.719-728 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02001-8 ;PMID: 35101175Full text available |
|
15 |
Material Type: Article
|
A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by StatinsJournal of cardiovascular pharmacology and therapeutics, 2022-01, Vol.27, p.10742484221138284The Author(s) 2022 ;ISSN: 1074-2484 ;EISSN: 1940-4034 ;DOI: 10.1177/10742484221138284 ;PMID: 36420979Full text available |
|
16 |
Material Type: Article
|
Statins and InflammationCurrent atherosclerosis reports, 2021-12, Vol.23 (12), p.80 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. ;EISSN: 1534-6242 ;DOI: 10.1007/s11883-021-00977-6 ;PMID: 34851454Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?Current atherosclerosis reports, 2021-10, Vol.23 (10), p.57 [Peer Reviewed Journal]The Author(s) 2021 ;2021. The Author(s). ;ISSN: 1523-3804 ;EISSN: 1534-6242 ;DOI: 10.1007/s11883-021-00955-y ;PMID: 34345932Digital Resources/Online E-Resources |
|
18 |
Material Type: Article
|
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international auditRheumatic & musculoskeletal diseases open, 2021-07, Vol.7 (2), p.e001724 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 2056-5933 ;EISSN: 2056-5933 ;DOI: 10.1136/rmdopen-2021-001724 ;PMID: 34244381Full text available |
|
19 |
Material Type: Article
|
Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international auditRMD Open, 2021-07, Vol.7 (2)publicDigital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?International journal of molecular sciences, 2021-04, Vol.22 (8), p.4182 [Peer Reviewed Journal]2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms22084182 ;PMID: 33920733Full text available |